Assessing and Managing Agitation During Early Recovery in Children With Moderate-to-Severe Traumatic Brain Injury in Australia: A National Survey.
Sarah J Knight, Taylor Jenkin, Vicki Anderson and 5 others
PMID 41031723WHAT IT FOUND
Most Australian clinicians managing agitated children with brain injury use general recovery scales, not agitation-specific tools.
They rely on environmental changes and individualized care, with family education key. Practice varies widely, and formal training on agitation management is often lacking.
Key findings
01While 78% of clinicians use standardized assessment tools, only 7% use specific agitation measures like the Agitated Behavior Scale.
02Non-pharmacological approaches are universal, with environmental modifications like dimming lights and reducing noise used by over 90% of respondents.
03Clinicians emphasize individualized management and family education, noting that agitation is a symptom of the injury rather than the child's character.
STILL TO COME
How it was doneWhat they foundWhat it means for PTsWhat it means for OTsWhat it means for SLPs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The sample was small (58 participants) and recruited via convenience and snowball sampling, which may attract clinicians with a specific interest in agitation. Participants were predominantly female and from Victoria, limiting generalizability to other regions or genders. Self-reported practices may not reflect actual clinical behavior. The survey adapted adult tools for pediatric use, which may not fully capture developmental differences in agitation presentation.
Declared interests
The authors declared no conflicts of interest.
The easy way to misread this
Do not interpret the widespread use of pharmacological agents as evidence of their efficacy. The study reports current practice patterns, not treatment outcomes, and the authors note that evidence for these medications in pediatric TBI is limited to case series and extrapolation from adult data.
Summarised by AI from the full paper, without a clinician reviewing it. Check it against the source before it changes what you do. Read it on PubMed →